Annual consolidated financial statements 2025
PDF | 996.64 KB
Business Development (M&A)
The Group continues to evaluate opportunities to expand across the continuum of care as part of its growth strategy and focus on delivering quality value-based clinical care to clients in a co-ordinated manner. Should you wish to contact Hirslanden with specific investment proposals, please send us an e-mail.
Investor Relations
Here you can find all the key figures that allow a comprehensive assessment of the Hirslanden Group.
Head of Mergers & Acquisitions
Franca Zanoni
Hirslanden AG
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark
Corporate Office
Boulevard Lilienthal 2
CH-8152 Glattpark